Cargando…

The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening

The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Kooyker, Arthur I., Toes‐Zoutendijk, Esther, Opstal‐van Winden, Annemieke W.J., Spaander, Manon C.W., Buskermolen, Maaike, van Vuuren, Hanneke J., Kuipers, Ernst J., van Kemenade, Folkert J., Ramakers, Chris, Thomeer, Maarten G.J., Dekker, Evelien, Nagtegaal, Iris D., de Koning, Harry J., van Leerdam, Monique E., Lansdorp‐Vogelaar, Iris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383838/
https://www.ncbi.nlm.nih.gov/pubmed/31853977
http://dx.doi.org/10.1002/ijc.32839
_version_ 1783563500947243008
author Kooyker, Arthur I.
Toes‐Zoutendijk, Esther
Opstal‐van Winden, Annemieke W.J.
Spaander, Manon C.W.
Buskermolen, Maaike
van Vuuren, Hanneke J.
Kuipers, Ernst J.
van Kemenade, Folkert J.
Ramakers, Chris
Thomeer, Maarten G.J.
Dekker, Evelien
Nagtegaal, Iris D.
de Koning, Harry J.
van Leerdam, Monique E.
Lansdorp‐Vogelaar, Iris
author_facet Kooyker, Arthur I.
Toes‐Zoutendijk, Esther
Opstal‐van Winden, Annemieke W.J.
Spaander, Manon C.W.
Buskermolen, Maaike
van Vuuren, Hanneke J.
Kuipers, Ernst J.
van Kemenade, Folkert J.
Ramakers, Chris
Thomeer, Maarten G.J.
Dekker, Evelien
Nagtegaal, Iris D.
de Koning, Harry J.
van Leerdam, Monique E.
Lansdorp‐Vogelaar, Iris
author_sort Kooyker, Arthur I.
collection PubMed
description The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut‐off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut‐off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non‐participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut‐off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut‐off were detected in the subsequent round.
format Online
Article
Text
id pubmed-7383838
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73838382020-07-27 The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening Kooyker, Arthur I. Toes‐Zoutendijk, Esther Opstal‐van Winden, Annemieke W.J. Spaander, Manon C.W. Buskermolen, Maaike van Vuuren, Hanneke J. Kuipers, Ernst J. van Kemenade, Folkert J. Ramakers, Chris Thomeer, Maarten G.J. Dekker, Evelien Nagtegaal, Iris D. de Koning, Harry J. van Leerdam, Monique E. Lansdorp‐Vogelaar, Iris Int J Cancer Cancer Therapy and Prevention The Dutch colorectal cancer (CRC) screening program started in 2014, inviting the target population biennially to perform a fecal immunochemical test (FIT). We obtained prospectively collected data from the national screening information‐system to present the results of the second round (2016) and evaluate the impact of increasing the FIT cut‐off halfway through the first round from 15 to 47 μg Hb/g feces on outcomes in the second round. Second round screening was done with a 47 μg Hb/g feces FIT cut‐off. Participants were classified based on first round participation status as either FIT (15,47) or FIT (47,47) participants, and previous nonparticipants. In total, 348,891 (75.9%) out of 459,740 invitees participated in the second round. Participation rates were 93.4% among previous participants and 21.0% among previous non‐participants. FIT(47,47) participants had a significantly higher detection rate of AN (15.3 vs. 10.4 per 1,000 participants) compared to FIT(15,47) participants in the second round, while their cumulative detection rate of AN over two rounds was significantly lower (45.6 vs. 52.6 per 1,000 participants). Our results showed that participation in the Dutch CRC screening program was consistently high and that second round detection rates depended on the first round FIT cut‐off. The cumulative detection over two rounds was higher among FIT(15,47) participants. These findings suggest that a substantial part of, but not all the missed findings in the first round due to the increased FIT cut‐off were detected in the subsequent round. John Wiley & Sons, Inc. 2020-01-09 2020-08-15 /pmc/articles/PMC7383838/ /pubmed/31853977 http://dx.doi.org/10.1002/ijc.32839 Text en © 2019 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Therapy and Prevention
Kooyker, Arthur I.
Toes‐Zoutendijk, Esther
Opstal‐van Winden, Annemieke W.J.
Spaander, Manon C.W.
Buskermolen, Maaike
van Vuuren, Hanneke J.
Kuipers, Ernst J.
van Kemenade, Folkert J.
Ramakers, Chris
Thomeer, Maarten G.J.
Dekker, Evelien
Nagtegaal, Iris D.
de Koning, Harry J.
van Leerdam, Monique E.
Lansdorp‐Vogelaar, Iris
The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title_full The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title_fullStr The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title_full_unstemmed The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title_short The second round of the Dutch colorectal cancer screening program: Impact of an increased fecal immunochemical test cut‐off level on yield of screening
title_sort second round of the dutch colorectal cancer screening program: impact of an increased fecal immunochemical test cut‐off level on yield of screening
topic Cancer Therapy and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383838/
https://www.ncbi.nlm.nih.gov/pubmed/31853977
http://dx.doi.org/10.1002/ijc.32839
work_keys_str_mv AT kooykerarthuri thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT toeszoutendijkesther thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT opstalvanwindenannemiekewj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT spaandermanoncw thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT buskermolenmaaike thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vanvuurenhannekej thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT kuipersernstj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vankemenadefolkertj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT ramakerschris thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT thomeermaartengj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT dekkerevelien thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT nagtegaalirisd thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT dekoningharryj thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vanleerdammoniquee thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT lansdorpvogelaariris thesecondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT kooykerarthuri secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT toeszoutendijkesther secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT opstalvanwindenannemiekewj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT spaandermanoncw secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT buskermolenmaaike secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vanvuurenhannekej secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT kuipersernstj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vankemenadefolkertj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT ramakerschris secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT thomeermaartengj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT dekkerevelien secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT nagtegaalirisd secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT dekoningharryj secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT vanleerdammoniquee secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening
AT lansdorpvogelaariris secondroundofthedutchcolorectalcancerscreeningprogramimpactofanincreasedfecalimmunochemicaltestcutofflevelonyieldofscreening